Dr. Chris Gemmiti will be attending Phacilitate at the Hyatt Regency in Miami this January. Please reach out to schedule a time to meet with him and learn more about the Sentien approach.
SCHEDULE A MEETING >

The Sentien team will be attending the 2019 J.P. Morgan Healthcare Conference. This event continues to be one of the life science industry’s largest conferences of the year. Contact us today to schedule a time to meet with our team and learn more about our business.
SCHEDULE A MEETING >

Watch Dr. Parekkadan’s interview at the World Advanced Therapies & Regenerative Medicine Congress in London here!
SEE VIDEO >

Watch Dr. Parekkadan’s TEDx Talk here!
SEE VIDEO >

Watch Sentien CEO Brian Miller’s presentation from the 2017 Cell & Gene Meeting on the Mesa here!
SEE VIDEO >

In September, our clinical trial was selected by Cell Trials Data as its Featured Advanced Cell Therapy Trial.
READ MORE >

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, announced that it has opened enrollment in its Phase 1/2 trial of SBI-101 for adult patients with acute kidney injury (AKI). This trial is Sentien’s first clinical program.
READ MORE >

Dr. Parekkadan will discuss Engineered Cell Therapeutics at the conference in NJ. His talk will be on Saturday, May 20th at 4pm.

Sentien Biotechnologies is a sponsor and exhibitor at the 2017 Cellular Therapeutics & Critical Care Conference being held from May 17-19 in San Francisco. This is the third in a series of conferences, entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine: Looking towards the Future.”